Top Story

CONVERGE day two buzz: Funding, compliance, and underestimating patients

Entrepreneurs, investors, and healthcare executives talked about strategy vs. innovation, the future of advance directives, and personalized medicine on day two of CONVERGE. [View the story “Best social media coverage from #mcconverge day two” on Storify] To see what else CONVERGE attendees were talking about, check out the favorites below and then a full list […]

By Ryan Amin on July 10, 2013

Entrepreneurs, investors, and healthcare executives talked about strategy vs. innovation, the future of advance directives, and personalized medicine on day two of CONVERGE.

[View the story “Best social media coverage from #mcconverge day two” on Storify]

To see what else CONVERGE attendees were talking about, check out the favorites below and then a full list here.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.